INTEKRIN
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity.
INTEKRIN
Industry:
Biotechnology Neuroscience Therapeutics
Founded:
2005-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.intekrin.com
Total Employee:
1+
Status:
Closed
Contact:
650-941-5501
Email Addresses:
[email protected]
Total Funding:
66.42 M USD
Technology used in webpage:
GoDaddy DNS GoDaddy Intermedia
Current Advisors List
Investors List
Asset Management Company
Asset Management Company investment in Venture Round - InteKrin
Asset Management Company
Asset Management Company investment in Venture Round - InteKrin
Asset Management Company
Asset Management Company investment in Series C - InteKrin
Amgen Ventures
Amgen Ventures investment in Series C - InteKrin
Vivo Capital
Vivo Capital investment in Series C - InteKrin
Skyline Ventures
Skyline Ventures investment in Series C - InteKrin
OrbiMed
OrbiMed investment in Series C - InteKrin
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series C - InteKrin
Sofinnova Investments
Sofinnova Investments investment in Series C - InteKrin
Sears Capital Management
Sears Capital Management investment in Series C - InteKrin
Official Site Inspections
http://www.intekrin.com
- Host name: 142.215.74.97.host.secureserver.net
- IP address: 97.74.215.142
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "InteKrin"
InteKrin - Crunchbase Company Profile & Funding
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and …See details»
Organization | InteKrin Therapeutics, Inc. - Purdue University
InteKrin Therapeutics, Inc. Report issue. For profit Phase 2. Founded: Los Altos CA United States ... Organization Overview. First Clinical Trial. 2005 NCT00952445. First Marketed Drug. None …See details»
InteKrin Therapeutics, Inc. - Crunchbase Company Profile & Funding
Alternatives and possible competitors to InteKrin Therapeutics, Inc. may include Bestukpharma.com, Tissue Overseas, and Symphony Allegro. Unlock even more features with …See details»
Coherus Biosciences acquires InteKrin - 2014-02-12 - Crunchbase
InteKrin InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders. Acquiring Organization: Coherus …See details»
InteKrin Company Profile 2024: Valuation, Investors, Acquisition ...
InteKrin was founded in 2005. Who is the founder of InteKrin? Christos Mantzoros Ph.D and Dennis Lanfear are the founders of InteKrin. Where is InteKrin headquartered? InteKrin is …See details»
Coherus Biosciences Inc acquired InteKrin Therapeutics, Inc. from …
Feb 23, 2014 The transaction is subject to execution of escrow agreement, rights agreement, voting agreement, management rights agreement, approval by shareholders of Coherus …See details»
InteKrin Therapeutics Appoints Linda Higgins, PhD as President …
May 11, 2010 InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in …See details»
Dennis M. Lanfear - Coherus BioSciences
Denny Lanfear founded Coherus in 2010 and is President and Chief Executive Officer. Denny is a biopharmaceutical leader with a proven track record of entrepreneurial success and achievement. In 2010, after decades working in …See details»
InteKrin - Contacts, Employees, Board Members, Advisors & Alumni
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.See details»
Organization, dynamics and mechanoregulation of integrin
Sep 27, 2022 Here we review how the interplay of mechanical forces, biochemical signalling and molecular self-organization determines the composition, organization, mechanosensitivity and …See details»
Organization, dynamics and mechanoregulation of integrin …
Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions Nat Rev Mol Cell Biol. 2023 Feb;24(2):142-161. doi: 10.1038/s41580-022-00531-5. Epub 2022 Sep 27. …See details»
Organisation, dynamics and mechanoregulation of integrin …
The molecular chronology of initial IAC organization in the protruding lamellipodia of migrating cells 62 has been probed by Fluorescence Correlation Spectroscopy , which identified kindlin …See details»
InteKrin Therapeutics Appoints Linda Higgins, PhD as President …
May 10, 2010 InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in …See details»
Integrin Organization: Linking Adhesion Ligand Nanopatterns with ...
Apr 4, 2011 The striking qualitative differences in integrin organization that can be seen in Fig. 2 (ad) suggest that there may be ways to quantify integrin organization in searching for …See details»
InteKrin - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Debt Financing - InteKrin . 2: …See details»
Intrinsic self-organization of integrin nanoclusters within focal ...
Nov 20, 2023 Altering this spatial organization using cyclo-RGD functionalized Titanium nanodiscs (of 100 nm, corroborating to the integrin nanocluster size) spaced at intervals of 300 …See details»
The role and regulation of integrins in cell migration and invasion
Sep 30, 2024 As the role of integrins in mechanotransduction and the nanoscale organization of components in IACs have recently been covered elsewhere, we will not go into great detail on …See details»
CJSC InteKrin - Crunchbase Company Profile & Funding
CJSC InteKrin is located in Moscow, Moscow City, Russian Federation. Who are CJSC InteKrin 's competitors? Alternatives and possible competitors to CJSC InteKrin may include Palmira …See details»
Integrins Modulate Extracellular Matrix Organization to Control …
Sep 7, 2020 ECM organization and density controls blood progenitor behavior by modulating multiple signaling pathways, including bone morphogenetic protein (BMP) and Hedgehog (Hh). …See details»
InteKrin - Tech Stack, Apps, Patents & Trademarks - Crunchbase
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.See details»